诺和诺德几乎将其与 Valo Health（一家专注于将人工智能应用于药物研发的公司）的研发联盟规模扩大了一倍，在原有的 11 个项目基础上新增了 9 个 ...

智通财经APP获悉，丹麦制药巨头 诺和诺德 (NVO.US)与人工智能生物科技公司Valo Health周三宣布扩大合作，旨在加速心脏代谢疾病新疗法的研发。 根据 ...

Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday an agreement to expand their existing collaboration to discover and develop new treatments ...

Novo Nordisk expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human data and artificial intelligence. The deal ...

Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and billions on the back end—to apply artificial intelligence to up to ...

Jan 8 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for ...